BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3094371)

  • 21. Sodium imbalance in a patient receiving total parenteral nutrition.
    Sunyecz L; Mirtallo JM
    Clin Pharm; 1993 Feb; 12(2):138-49. PubMed ID: 8453863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive approach to intravenous feeding of the critically ill patient.
    Lumb PD; Dalton B; Bryan-Brown CW; Donnelly C
    Heart Lung; 1979; 8(1):71-80. PubMed ID: 103864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More efficient system for preparing total parenteral nutrient solutions.
    Condella F; Baptista RJ; Griffin RE
    Am J Hosp Pharm; 1983 Dec; 40(12):2146-9. PubMed ID: 6419587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implications.
    Petros WP; Shank WA
    Hosp Pharm; 1986 Jul; 21(7):648-9, 654-6. PubMed ID: 10311603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of ranitidine hydrochloride in total parenteral nutrient solution.
    Walker SE; Bayliff CD
    Am J Hosp Pharm; 1985 Mar; 42(3):590-2. PubMed ID: 3920904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total parenteral nutrition in the surgical patient: a meta-analysis.
    Heyland DK; Montalvo M; MacDonald S; Keefe L; Su XY; Drover JW
    Can J Surg; 2001 Apr; 44(2):102-11. PubMed ID: 11308231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sterility of total parenteral nutrient solutions stored at room temperature for seven days.
    Takagi J; Khalidi N; Wolk RA; Tjolsen E; de Leon R; Wesley JR
    Am J Hosp Pharm; 1989 May; 46(5):973-7. PubMed ID: 2499191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic investigation of the use of three-compartment total parenteral nutrition bag: prospective randomized unblinded controlled study.
    Pichard C; Schwarz G; Frei A; Kyle U; Jolliet P; Morel P; Romand JA; Sierro C
    Clin Nutr; 2000 Aug; 19(4):245-51. PubMed ID: 10952795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
    Brard L; Weitzen S; Strubel-Lagan SL; Swamy N; Gordinier ME; Moore RG; Granai CO
    Gynecol Oncol; 2006 Oct; 103(1):176-80. PubMed ID: 16564074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Total parenteral nutrition in critical patients. The metabolic-nutritional aspects and effects on immune function of 2 different isocaloric-isonitrogenous regimens].
    Da Pont MC; Pezzana A; Demagistris A; Balzola F; Cassader M; Boggio Bertinet D; Balzola F
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):17-26. PubMed ID: 8204701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fructose-1,6-diphosphate-added total parenteral nutrition in septic animals and stressed patients.
    Shu Z; Li J
    Chin Med J (Engl); 2001 Nov; 114(11):1171-5. PubMed ID: 11729513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morbidity and mortality of short-bowel syndrome in infants with abdominal wall defects.
    Thakur A; Chiu C; Quiros-Tejeira RE; Reyen L; Ament M; Atkinson JB; Fonkalsrud EW
    Am Surg; 2002 Jan; 68(1):75-9. PubMed ID: 12467323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Work analysis of an admixture service.
    Sebastian G; Thielke TS
    Am J Hosp Pharm; 1983 Dec; 40(12):2149-53. PubMed ID: 6419588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF.
    Fitzgerald KA; MacKay MW
    Am J Hosp Pharm; 1987 Jun; 44(6):1396-400. PubMed ID: 3113238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of bioavailability of aluminium in neonatal parenteral nutrition solutions by prior complexation in the dosage form.
    Hayes P; Martin TP; Pybus J; Hunt J; Broadbent RS
    J Parenter Sci Technol; 1992; 46(5):169-75. PubMed ID: 1432456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early enteral nutrition in cancer patients subjected to a total gastrectomy].
    Papapietro K; Díaz E; Csendes A; Díaz JC; Burdiles P; Maluenda F; Braghetto I; Llanos JL; D'Acuña S; Rappoport J
    Rev Med Chil; 2002 Oct; 130(10):1125-30. PubMed ID: 12491829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nutrition support team led by general surgeons decreases inappropriate use of total parenteral nutrition on a surgical service.
    Saalwachter AR; Evans HL; Willcutts KF; O'Donnell KB; Radigan AE; McElearney ST; Smith RL; Chong TW; Schirmer BD; Pruett TL; Sawyer RG
    Am Surg; 2004 Dec; 70(12):1107-11. PubMed ID: 15663055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral nutrition given to children and adults: experience of a procedure applied in Mexico.
    Calderón-Guzmán D; Hernández-García E; Barragán-Mejía G; Guille-Pérez A; Juárez-Olguín H
    Proc West Pharmacol Soc; 2008; 51():35-7. PubMed ID: 19544671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total parenteral nutrition (TPN) in the critically ill patient.
    Lerda R; Riberi A; Menardo V; Beltrutti DP
    Panminerva Med; 1991; 33(2):115-8. PubMed ID: 1923554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Audit of ranitidine administration in parenteral nutrient solutions.
    Hershey AG; Rosen GH; Foster MD; Johnson DS; Martir-Herrero ML; Krieger J; Oh SM
    Am J Hosp Pharm; 1991 Jan; 48(1):104-7. PubMed ID: 1900386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.